TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults
HIV-patients have excess of pneumococcal infection. We immunized 40 HIV-patients twice with pneumococcal conjugate vaccine (Prevnar, Pfizer) +/− a TLR9 agonist (CPG 7909). Peripheral blood mononuclear cells were stimulated with pneumococcal polysaccharides and cytokine concentrations measured. The C...
Saved in:
Main Authors: | Rasmus Offersen (Author), Jesper Melchjorsen (Author), Søren R. Paludan (Author), Lars Østergaard (Author), Martin Tolstrup (Author), Ole S. Søgaard (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2012-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune checkpoints and the HIV-1 reservoir: proceed with caution
by: Rikke Olesen, et al.
Published: (2016) -
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
by: Marina Luchner, et al.
Published: (2021) -
Antibody persistence after pneumococcal conjugate vaccination in patients with chronic lymphocytic leukemia
by: Vesa Lindström, et al.
Published: (2018) -
Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures
by: Juliette Fortpied, et al.
Published: (2018) -
Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency ex vivo without T cell activation
by: Jesper D. Gunst, et al.
Published: (2019)